成都先导收盘上涨5.08%，滚动市盈率90.75倍，总市值59.62亿元

Group 1 - The core viewpoint of the article highlights Chengdu Xian Dao's stock performance, with a closing price of 14.88 yuan, up 5.08%, and a rolling PE ratio of 90.75, marking a new low in 17 days, with a total market value of 5.962 billion yuan [1] - Chengdu Xian Dao ranks 37th in the medical services industry, which has an average PE ratio of 40.74 and a median of 42.36 [1] - As of March 31, 2025, the number of shareholders for Chengdu Xian Dao increased to 16,254, with an average holding value of 352,800 yuan and an average holding of 27,600 shares [1] Group 2 - Chengdu Xian Dao specializes in drug discovery and development services related to DEL technology, including DEL screening services, custom DEL libraries, FBDD/SBDD, custom drug development, compound structure intellectual property transfer, and other related services [1] - In the latest quarterly report for Q1 2025, the company reported revenue of 107 million yuan, a year-on-year decrease of 0.60%, while net profit reached 28.2844 million yuan, a year-on-year increase of 102.90%, with a gross profit margin of 51.87% [1]